A bone substitute composed of polymethyl-methacrylate bone cement and Bio-Gene allogeneic bone promotes osteoblast viability, adhesion and differentiation

2020 ◽  
pp. 1-9
Author(s):  
Zhikun Wang ◽  
Zaixue Li ◽  
Xiansen Zhang ◽  
Yingfeng Yu ◽  
Qingyu Feng ◽  
...  
Keyword(s):  
Biological Activity ◽  
Bone Cement ◽  
Bone Substitute ◽  
Biological Properties ◽  
Live Cells ◽  
Control Group ◽  
Allogeneic Bone ◽  
Gene Group ◽  
Pmma Bone Cement ◽  
Pmma Cement

BACKGROUND: Increasing reports on new cement formulations that address the shortcomings of PMMA bone cements and various active components have been introduced to improve the biological activity of PMMA cement. OBJECTIVE: Evaluating the biological properties of PMMA cements-reinforced with Bio-Gene allogeneic bone. METHODS: The MC3T3-E1 mouse osteoblast-like cells were utilized to determine the effects of Bio-Gene + PMMA on osteoblast viability, adhesion and differentiation. RESULTS: The combination of allogeneic bone and PMMA increased the number of adherent live cells compared to both control group and PMMA or Bio-Gene group. Scanning electron microscopy observed that the number of cells adhered to Bio-Gene + PMMA was larger than Bio-Gene and PMMA group. Compared with the control and PMMA or Bio-Gene group, the level of ALP and the number of calcium nodules after osteoinduction was remarkably enhanced in Bio-Gene + PMMA group. Additionally, the combination of Bio-Gene and PMMA induced the protein expression of osteocalcin, osterix and collagen I. CONCLUSION: The composition of PMMA and allogeneic bone could provide a more beneficial microenvironment for osteoblast proliferation, adhesion and differentiation. PMMA bone cement reinforced with Bio-Gene allogeneic bone may act as a novel bone substitute to improve the biological activity of PMMA cement.

scholarly journals Facial profile changes due to bone cement graft to manage the hyperactive muscles of the gingival smile

2020 ◽  
Vol 25 (2) ◽  
pp. 44-51
Author(s):  
Érica Miranda de Torres ◽  
José Valladares-Neto ◽  
Karina de Oliveira Bernades ◽  
Luis Fernando Naldi ◽  
Hianne Miranda de Torres ◽  
...  
Keyword(s):  
Bone Cement ◽  
Wilcoxon Test ◽  
Upper Lip ◽  
Facial Profile ◽  
Significance Level ◽  
Nasolabial Angle ◽  
Pmma Bone Cement ◽  
Graft Thickness ◽  
Profile Changes ◽  
Pmma Cement

ABSTRACT Objective: To evaluate facial profile changes promoted by polymethyl methacrylate (PMMA) cement graft to reduce excessive gingival display due to hyperactivity of the elevator muscles of the upper lip during smiling. Methods: Eleven patients (all females, age range: 20 to 43 years) presenting gingival smile that were treated with PMMA cement grafts in a private clinic were selected for this retrospective study. Three angular and ten linear cephalometric facial profile measurements were performed preoperatively (baseline, T1) and at least 6 months postoperatively (T2). Differences between T1 and T2 were verified by Wilcoxon test, and the correlation between the thickness of the graft and facial profile changes was statistically evaluated by Spearman’s Coefficient test. The significance level was set at p< 0.05. Results: The nasolabial angle (p= 0.03) and the labial component of the nasolabial angle showed statistically significant differences (p= 0.04), with higher values in T2. No correlations were found between the graft thickness and the statistically significant facial profile changes (p> 0.05). Conclusions: The PMMA bone cement graft projected the upper lip forward, thereby increasing the nasolabial angle without affecting the nasal component. No correlations between the graft thickness and the facial profile changes were detected.

scholarly journals Enhanced osteointegration of poly(methylmethacrylate) bone cements by incorporating strontium-containing borate bioactive glass

2017 ◽  
Vol 14 (131) ◽  
pp. 20161057 ◽  
Author(s):  
Xu Cui ◽  
Chengcheng Huang ◽  
Meng Zhang ◽  
Changshun Ruan ◽  
Songlin Peng ◽  
...  
Keyword(s):  
Bioactive Glass ◽  
Bone Cement ◽  
Setting Time ◽  
Composite Cement ◽  
Collagen Secretion ◽  
Pmma Bone Cement ◽  
Borate Bioactive Glass ◽  
Composite Cements ◽  
Pmma Cement

Although poly(methylmethacrylate) (PMMA) cements are widely used in orthopaedics, they have numerous drawbacks. This study aimed to improve their bioactivity and osseointegration by incorporating strontium-containing borate bioactive glass (SrBG) as the reinforcement phase and bioactive filler of PMMA cement. The prepared SrBG/PMMA composite cements showed significantly decreased polymerization temperature when compared with PMMA and retained properties of appropriate setting time and high mechanical strength. The bioactivity of SrBG/PMMA composite cements was confirmed in vitro , evidenced by ion release (Ca, P, B and Sr) from SrBG particles. The cellular responses of MC3T3-E1 cells in vitro demonstrated that SrBG incorporation could promote adhesion, migration, proliferation and collagen secretion of cells. Furthermore, our in vivo investigation revealed that SrBG/PMMA composite cements presented better osseointegration than PMMA bone cement. SrBG in the composite cement could stimulate new-bone formation around the interface between the composite cement and host bone at eight and 12 weeks post-implantation, whereas PMMA bone cement only stimulated development of an intervening connective tissue layer. Consequently, the SrBG/PMMA composite cement may be a better alternative to PMMA cement in clinical applications and has promising orthopaedic applications by minimal invasive surgery.

Bioactive bone cements

1998 ◽  
Vol 212 (2) ◽  
pp. 113-120 ◽  
Author(s):  
E J Harper
Keyword(s):  
Bone Cement ◽  
Mechanical Characteristics ◽  
Cement Mantle ◽  
Polymerization Reaction ◽  
Bone Cements ◽  
Surgical Results ◽  
Pmma Bone Cement ◽  
Bioactive Agents ◽  
Pmma Cement ◽  
Surrounding Bone

Poly (methylmethacrylate) (PMMA) bone cement, used to fix implants into the bone, produces good surgical results if used correctly. However, prostheses do eventually become loose and the breakdown of the cement mantle is a factor in this failure. Limitations of PMMA cement, which lead to problems with the fixation of the implant, include its mechanical characteristics and its influence upon surrounding bone, associated with the polymerization reaction. A bioactive bone cement is particularly designed to produce a better interface between the cement and bone. However, an improvement in mechanical properties, especially fatigue, creep and fracture toughness, are an added necessary requirement to increase the lifetime of a cemented implant. The development of a bioactive cement has been conducted mainly in two ways; firstly, to improve existing PMMA cement by the addition of various bioactive agents and secondly, to design an alternative matrix for the bioactive material to be combined with. The most promising investigations which have been conducted, along with their relative benefits and drawbacks, are discussed.

scholarly journals In Vitro and In Vivo Evaluation of Vancomycin-Loaded PMMA Cement in Combination with Ultrasound and Microbubbles-Mediated Ultrasound

2015 ◽  
Vol 2015 ◽  
pp. 1-7 ◽  
Author(s):  
Tiao Lin ◽  
Xun-Zi Cai ◽  
Ming-Min Shi ◽  
Zhi-Min Ying ◽  
Bin Hu ◽  
...  
Keyword(s):  
Bone Cement ◽  
Joint Infection ◽  
Study Groups ◽  
In Vivo Evaluation ◽  
Pmma Bone Cement ◽  
Prosthetic Joint ◽  
New Zealand White Rabbits ◽  
Pmma Cement

Ultrasound (US) has been used to increase elution of antibiotic from an antibiotic-loaded poly(methyl methacrylate) (PMMA) bone cement (ALBC). We aimed to further investigate whether microbubbles-mediated US (US + MB) facilitate elution of vancomycin (VAN) from cylindrical specimens and enhance the activity of the eluted antibiotic againstStaphylococcus aureus(S. aureus) in vitro. The study groups comprised cylindrical bone cement fabricated with VAN (VAN), ALBC using US (VAN + US), and ALBC using MB-mediated US (VAN + US + MB). We also carried out an in vivo study involving the activity of VAN from cylindrical cement implanted in tibiae of New Zealand white rabbits inoculated withS. aureus. We found that (1) in vitro, elution from VAN + US + MB cylinders was significantly higher than from either the VAN or VAN + US specimens; (2) the activity of the eluted VAN from the VAN + US + MB cylinders against planktonicS. aureuswas significantly higher than from either the control or VAN or VAN + US specimens; and (3) in the rabbits, the activity of the eluted VAN from the VAN + US + MB cylinders againstS. aureuswas significantly higher than from either the control or VAN or VAN + US specimens. The present results suggest that VAN-loaded PMMA cement irradiated with MB-mediated US may have a role in controlling prosthetic joint infection.

scholarly journals Fabrication of PLLA/C3S Composite Membrane for the Prevention of Bone Cement Leakage

Polymers ◽  
2019 ◽  
Vol 11 (12) ◽  
pp. 1971 ◽  
Author(s):  
Tsai-Hsueh Leu ◽  
Yang Wei ◽  
Yi-Shi Hwua ◽  
Xiao-Juan Huang ◽  
Jung-Tang Huang ◽  
...  
Keyword(s):  
Bone Cement ◽  
Material Design ◽  
Posterior Wall ◽  
Cement Leakage ◽  
Tricalcium Silicate ◽  
Spine Fractures ◽  
Vertebral Bone ◽  
Pmma Bone Cement ◽  
Degradation Properties ◽  
Pmma Cement

Kyphoplasty is an important treatment for stabilizing spine fractures due to osteoporosis. However, leakage of polymethyl-methacrylate (PMMA) bone cement during this procedure into the spinal canal has been reported to cause many adverse effects. In this study, we prepared an implantable membrane to serve as a barrier that avoids PMMA cement leakage during kyphoplasty procedures through a hybrid composite made of poly-l-lactic acid (PLLA) and tricalcium silicate (C3S), with the addition of C3S into PLLA matrix, showing enhanced mechanical and anti-degradation properties while keeping good cytocompatibility when compared to PLLA alone and most importantly, when this material design was applied under standardized PMMA cement injection conditions, no posterior wall leakage was observed after the kyphoplasty procedure in pig lumbar vertebral bone models. Testing results assess its effectiveness for clinical practice.

scholarly journals Properties of PMMA Bone Cement Modified with Nano-hydroxyapatite and Acetone

2019 ◽  
Vol 2 (4) ◽  
pp. 489
Author(s):  
Amin Zaza ◽  
Mohamed Habib ◽  
Nabil Fatahalla
Keyword(s):  
Bone Cement ◽  
Young’S Modulus ◽  
High Performance ◽  
Young's Modulus ◽  
Nano Particles ◽  
Polymerization Temperature ◽  
Compression Tests ◽  
Residual Monomer ◽  
Pmma Bone Cement ◽  
Pmma Cement

Fracture in the adjacent levels is one of the consequences to the use of commercial poly methylmethacrylate (PMMA) bone cement. Modified PMMA with a reduced Young’s modulus was found to be safer for cancellous bone augmentation procedures. The aim of this research was to study the effect of adding hydroxyapatite (HA) nano-particles and acetone on different properties of PMMA cement. A commercial PMMA cement was used as a model for bone cement. Three groups of modified PMMA/nano-HA were investigated by adding 2, 4 and 6 wt. % of HA. Acetone as a porogen mixed with distilled water in different amounts (A/W: 1:1, 2:1.5 and 2:1g) was used to produce porous PMMA cement. The residual monomer, polymerization and mechanical properties under tension and compression tests were investigated. Young’s modulus detected from compression test decreased from 826.5±10 to 728±66 MPa by adding 6wt.% HA. Adding acetone to PMMA with 2:1.5g (A/W) has decreased the compressive Young’s modulus to 753±38 MPa. High Performance Liquid Chromatography (HPLC) measurements were carried out with intervals of 2 hours, 6 hours and 24 hours to evaluate the residual monomer for all groups. The amount of residual monomer has decreased after 24 hours of curing by adding acetone and nano-HA. Modifying PMMA by HA and acetone have inconsistent effect on the polymerization temperature. It was concluded that HA and acetone can be used to reduce the stiffness and residual monomer with enhanced biocompatibility of the commercial PMMA bone cement.

scholarly journals Antibiotic Containing Bone Substitute in Major Hip Surgery: A Long Term Gentamicin Elution Study

2018 ◽  
Vol 3 (2) ◽  
pp. 68-72 ◽  
Author(s):  
Mindaugas Stravinskas ◽  
Malin Nilsson ◽  
Peter Horstmann ◽  
Michael Mørk Petersen ◽  
Sarunas Tarasevicius ◽  
...  
Keyword(s):  
Methyl Methacrylate ◽  
Hip Fractures ◽  
Hip Arthroplasty ◽  
Bone Substitute ◽  
Calcium Sulphate ◽  
Pmma Bone Cement ◽  
One Year ◽  
Pmma Cement

Abstract. Objectives: The objective is to present the antibiotic elution from a locally implanted gentamicin containing hydroxyapatite and calcium sulphate bone substitute with an extended follow up of 30 days.We also compare the pharmacokinetics of the ceramic bone substitute with a published study on gentamicin containing poly (methyl methacrylate) (PMMA) bone cement used in primary total hip arthroplasty.Methods: Gentamicin release was measured in the urine for a month and the serum for 4 days in 10 patients operated for trochanteric hip fractures and 10 patients in uncemented hip revisions. 17 patients were followed up at one year and 3 patients at 6 months.Results and Discussion: The gentamicin concentrations measured in serum were low and approximately 100 times less than in urine during the first days, indicating high local concentrations at the implant site. The elution from the biphasic bone substitute showed a stronger burst and higher gentamicin concentrations for the first week compared to that reported for PMMA used in hip arthroplasty. Also, for the bone substitute a complete gentamicin elution was obtained after 30 days, while for the PMMA cement sub-inhibitory MIC levels of gentamicin were still present in urine 60 days past surgery. No infections were detected.Conclusions: A new biphasic bone substitute containing antibiotics could potentially be used to prevent infection in patients treated for trochanteric hip fractures or uncemented hip revisions. The gentamicin elution from the bone substitute is efficient with high initial local gentamicin concentrations and complete release at 30 days.

scholarly journals Minimally invasive injectable lumbar interbody fusion with mineralized collagen-modified PMMA bone cement: A new animal model

2020 ◽  
Vol 18 ◽  
pp. 228080002090363
Author(s):  
Jianjun Kong ◽  
Jianqing Ma ◽  
Zhanyong Wu ◽  
Huiwang Wang ◽  
Xiangping Peng ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Animal Model ◽  
Minimally Invasive ◽  
Bone Cement ◽  
Interbody Fusion ◽  
Autogenous Bone ◽  
Control Group ◽  
Lumbar Interbody Fusion ◽  
Pmma Bone Cement ◽  
Mineralized Collagen

This study was to develop a feasible and safe animal model for minimally invasive injectable lumbar interbody fusion using a novel biomaterial, mineralized collagen-polymethylmethacrylate bone cement (MC-PMMA), with unilateral pedicle screw fixation in an in vivo goat model. Eight goats ( Capra aegagrus hircus) were divided into three groups: MC-PMMA, unmodified commercial-polymethylmethacrylate bone cement (UC-PMMA), and a control group (titanium cage filled with autogenous bone, TC-AB). Each group of goats was treated with minimally invasive lumbar interbody fusion at the L3/L4 and L5/L6 disc spaces (injected for MC-PMMA and UC-PMMA, implanted for TC-AB). The pedicle screws were inserted at the L3, L4, L5, and L6 vertebrae, respectively, and fixed on the left side. The characteristics of osteogenesis and bone growth were assessed at the third and the sixth month, respectively. The methods of evaluation included the survival of each animal, X-ray imaging, and 256-layer spiral computed tomography (256-CT) scanning, imaged with three-dimensional microfocus computed tomography (micro-CT), and histological analysis. The results showed that PMMA bone cement can be extruded smoothly after doping MC, the MC-PMMA integrates better with bone than the UC-PMMA, and all goats recovered after surgery without nerve damage. After 3 and 6 months, the implants were stable. New trabecular bone was observed in the TC-AB group. In the UC-PMMA group a thick fibrous capsule had formed around the implants. The MC-PMMA was observed to have perfect osteogenesis and bone ingrowth to adjacent bone surface. Minimally invasive injectable lumbar interbody fusion using MC-PMMA bone cement was shown to have profound clinical value, and the MC-PMMA showed potential application prospects.

Thermal Curing and Strength of PMMA Bone Cement

2003 ◽  
Author(s):  
M. A. Sanchez ◽  
W. Sutton ◽  
W. Rizk ◽  
J. Tompkins
Keyword(s):  
Bone Cement ◽  
Room Temperature ◽  
Initial Temperature ◽  
Exothermic Reaction ◽  
Bone Cements ◽  
Thermal Curing ◽  
Heat Transfer Modeling ◽  
Pmma Bone Cement ◽  
Maximum Reaction ◽  
Pmma Cement

Many current bone cements have proprietary minor ingredients that affect the chemical kinetics and heat transfer modeling of the exothermic reaction during bone cement polymerization. In addition, the geometry and the method of cooling/curing the bone cement can vary by application. A method for modeling energy generation, based on temperature measurement of various geometries and conditions, expresses the exothermic reaction and the duration with respect to time. Reaction from the bone cement can yield temperatures above 110°C for the air convective cooling boundary condition. Experiments show that by using cold irrigation cooling (saline) with an initial temperature of 1.5°C, the maximum reaction temperature of the PMMA cement approaches 40°C depending upon the thickness of the cement. For bone cement cooled in air and saline at room temperature, the exothermic reaction begins around 400 seconds (8 min) after the compounds are mixed. When cold saline is applied, the time-delay of the reaction is approximately 300 additional seconds compared to the two room temperature cases. Finally, based on compression testing, the structural behavior of the PMMA cement is improved when the material is cured in a slower and wet environment.

scholarly journals Release characteristics of enoxaparin sodium-loaded polymethylmethacrylate bone cement

2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Hui Sun ◽  
Xinzhe Ma ◽  
Zhiyong Li ◽  
Jianning Liu ◽  
Wei Wang ◽  
...  
Keyword(s):  
Bone Cement ◽  
Enoxaparin Sodium ◽  
Parallel Line ◽  
Control Group ◽  
Coagulation Therapy ◽  
Pmma Bone Cement ◽  
Long Time ◽  
Application Potential ◽  
Loading Amount ◽  
Experimental Group

Abstract Background This study aimed to prepare the polymethylmethacrylate (PMMA) bone cement release system with different concentrations of enoxaparin sodium (ES) and to investigate the release characteristics of ES after loading into the PMMA bone cement. Methods In the experimental group, 40 g Palacos®R PMMA bone cement was loaded with various amount of ES 4000, 8000, 12,000, 16,000, 20,000, and 24,000 AXaIU, respectively. The control group was not loaded with ES. Scanning electron microscopy (SEM) was used to observe the surface microstructure of the bone cement in the two groups. In the experiment group, the mold was extracted continuously with pH7.4 Tris-HCL buffer for 10 days. The extract solution was collected every day and the anti-FXa potency was measured. The experiment design and statistical analysis were conducted using a quantitative response parallel line method. Results Under the SEM, it was observed that ES was filled in the pores of PMMA bone cement polymer structure and released from the pores after extraction. There was a burst effect of the release. The release amount of ES on the first day was 0.415, 0.858, 1.110, 1.564, 1.952, and 2.513, respectively, from the six groups with various ES loading amount of 4000, 8000, 12,000, 16,000, 20,000, and 24,000 AXaIU, all reaching the peak of release on the first day. The release decreased rapidly on the next day and entered the plateau phase on the fourth day. Conclusion The prepared ES-PMMA bone cement has high application potential in orthopedic surgery. ES-PMMA bone cement shows good drug release characteristics. The released enoxaparin sodium has a local anti-coagulant effect within 24 h after application, but it will not be released for a long time, which is complementary to postoperative anti-coagulation therapy.

Sign in / Sign up

Export Citation Format

Share Document